{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:17:25Z","timestamp":1779214645182,"version":"3.51.4"},"reference-count":40,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2023.0205","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T11:36:15Z","timestamp":1698147375000},"source":"Crossref","is-referenced-by-count":7,"title":["Diseases of the coronary microcirculation: diagnosis and treatment"],"prefix":"10.3238","author":[{"given":"Helen","family":"Ullrich-Daub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Daub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Olschewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"M\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"10.3238\/arztebl.m2023.0205_ref1","doi-asserted-by":"crossref","unstructured":"Ong P, Camici PG, Beltrame JF, et al.: International standardization of diagnostic criteria for microvascular angina. Int J Cardiol 2018; 250: 16–20.","DOI":"10.1016\/j.ijcard.2017.08.068"},{"key":"10.3238\/arztebl.m2023.0205_ref2","doi-asserted-by":"crossref","unstructured":"Patel MR, Peterson ED, Dai D, et al.: Low diagnostic yield of elective coronary angiography. N Engl J Med 2010; 362: 886–95.","DOI":"10.1056\/NEJMoa0907272"},{"key":"10.3238\/arztebl.m2023.0205_ref3","doi-asserted-by":"crossref","unstructured":"Rahman H, Corcoran D, Aetesam-Ur-Rahman M, Hoole SP, Berry C, Perera D: Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory. Heart 2019; 105: 1536–42.","DOI":"10.1136\/heartjnl-2019-315042"},{"key":"10.3238\/arztebl.m2023.0205_ref4","doi-asserted-by":"crossref","unstructured":"Ford TJ, Stanley B, Good R, et al.: Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial. J Am Coll Cardiol 2018; 72: 2841–55.","DOI":"10.1016\/j.jacc.2018.09.006"},{"key":"10.3238\/arztebl.m2023.0205_ref5","doi-asserted-by":"crossref","unstructured":"Camici PG, Crea F: Coronary microvascular dysfunction. N Engl J Med 2007; 356: 830–40.","DOI":"10.1056\/NEJMra061889"},{"key":"10.3238\/arztebl.m2023.0205_ref6","doi-asserted-by":"crossref","unstructured":"Perera D, Berry C, Hoole SP, et al.: Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation\/National Institute for Health Research Partnership. Heart 2022; 109: 88–95.","DOI":"10.1136\/heartjnl-2021-320718"},{"key":"10.3238\/arztebl.m2023.0205_ref7","doi-asserted-by":"crossref","unstructured":"Kunadian V, Chieffo A, Camici PG, et al.: An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on coronary pathophysiology & microcirculation endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J 2020; 41: 3504–20.","DOI":"10.1093\/eurheartj\/ehaa503"},{"key":"10.3238\/arztebl.m2023.0205_ref8","doi-asserted-by":"crossref","unstructured":"Gdowski MA, Murthy VL, Doering M, Monroy-Gonzalez AG, Slart R, Brown DL: Association of isolated coronary microvascular dysfunction with mortality and major adverse cardiac events: a systematic review and meta-analysis of aggregate data. J Am Heart Assoc 2020; 9: e014954.","DOI":"10.1161\/JAHA.119.014954"},{"key":"10.3238\/arztebl.m2023.0205_ref9","doi-asserted-by":"crossref","unstructured":"Crea F, Montone RA, Rinaldi R: Pathophysiology of Coronary Microvascular Dysfunction. Circ J 2022; 86: 1319–28.","DOI":"10.1253\/circj.CJ-21-0848"},{"key":"10.3238\/arztebl.m2023.0205_ref10","doi-asserted-by":"crossref","unstructured":"Del Buono MG, Montone RA, Camilli M, et al.: Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review. J Am Coll Cardiol 2021; 78: 1352–71.","DOI":"10.1016\/j.jacc.2021.07.042"},{"key":"10.3238\/arztebl.m2023.0205_ref11","doi-asserted-by":"crossref","unstructured":"Camici PG, d‘Amati G, Rimoldi O: Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol 2015; 12: 48–62.","DOI":"10.1038\/nrcardio.2014.160"},{"key":"10.3238\/arztebl.m2023.0205_ref12","unstructured":"Knuuti J, Wijns W, Saraste A, et al.: 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407–77."},{"key":"10.3238\/arztebl.m2023.0205_ref13","doi-asserted-by":"crossref","unstructured":"Lanza GA, Crea F: Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 2010; 121: 2317–25.","DOI":"10.1161\/CIRCULATIONAHA.109.900191"},{"key":"10.3238\/arztebl.m2023.0205_ref14","doi-asserted-by":"crossref","unstructured":"Ong P, Safdar B, Seitz A, Hubert A, Beltrame JF, Prescott E: Diagnosis of coronary microvascular dysfunction in the clinic. Cardiovasc Res 2020; 116: 841–55.","DOI":"10.1093\/cvr\/cvz339"},{"key":"10.3238\/arztebl.m2023.0205_ref15","doi-asserted-by":"crossref","unstructured":"Lethen H, Tries HP, Brechtken J, Kersting S, Lambertz H: Comparison of transthoracic Doppler echocardiography to intracoronary Doppler guidewire measurements for assessment of coronary flow reserve in the left anterior descending artery for detection of restenosis after coronary angioplasty. Am J Cardiol 2003; 91: 412–7.","DOI":"10.1016\/S0002-9149(02)03235-6"},{"key":"10.3238\/arztebl.m2023.0205_ref16","doi-asserted-by":"crossref","unstructured":"Schindler TH, Fearon WF, Pelletier-Galarneau M, et al.: Myocardial perfusion PET for the detection and reporting of coronary microvascular dysfunction: a JACC: cardiovascular imaging expert panel statement. JACC Cardiovasc Imaging 2023; 16: 536–48.","DOI":"10.1016\/j.jcmg.2022.12.015"},{"key":"10.3238\/arztebl.m2023.0205_ref17","doi-asserted-by":"crossref","unstructured":"Murthy VL, Naya M, Taqueti VR, et al.: Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation 2014; 129: 2518–27.","DOI":"10.1161\/CIRCULATIONAHA.113.008507"},{"key":"10.3238\/arztebl.m2023.0205_ref18","doi-asserted-by":"crossref","unstructured":"Thomson LE, Wei J, Agarwal M, et al.: Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women‘s Ischemia Syndrome Evaluation. Circ Cardiovasc Imaging 2015; 8: 10.1161.","DOI":"10.1161\/CIRCIMAGING.114.002481"},{"key":"10.3238\/arztebl.m2023.0205_ref19","doi-asserted-by":"crossref","unstructured":"Ford TJ, Ong P, Sechtem U, et al.: Assessment of vascular dysfunction in patients without obstructive coronary artery disease: why, how, and when. JACC Cardiovasc Interv 2020; 13: 1847–64.","DOI":"10.1016\/j.jcin.2020.05.052"},{"key":"10.3238\/arztebl.m2023.0205_ref20","doi-asserted-by":"crossref","unstructured":"Taqueti VR, Di Carli MF: Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J Am Coll Cardiol 2018; 72: 2625–41.","DOI":"10.1016\/j.jacc.2018.09.042"},{"key":"10.3238\/arztebl.m2023.0205_ref21","doi-asserted-by":"crossref","unstructured":"Pauly DF, Johnson BD, Anderson RD, et al.: In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women‘s Ischemia Syndrome Evaluation (WISE). Am Heart J 2011; 162: 678–84.","DOI":"10.1016\/j.ahj.2011.07.011"},{"key":"10.3238\/arztebl.m2023.0205_ref22","doi-asserted-by":"crossref","unstructured":"Kayikcioglu M, Payzin S, Yavuzgil O, Kultursay H, Can LH, Soydan I: Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J 2003; 24: 1999–2005.","DOI":"10.1016\/S0195-668X(03)00478-0"},{"key":"10.3238\/arztebl.m2023.0205_ref23","unstructured":"Leonardo F, Fragasso G, Rossetti E, et al.: Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance. Cardiologia 1999; 44: 1065–9."},{"key":"10.3238\/arztebl.m2023.0205_ref24","doi-asserted-by":"crossref","unstructured":"Cannon RO, 3rd, Watson RM, Rosing DR, Epstein SE: Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. Am J Cardiol 1985; 56: 242–6.","DOI":"10.1016\/0002-9149(85)90842-2"},{"key":"10.3238\/arztebl.m2023.0205_ref25","doi-asserted-by":"crossref","unstructured":"Sellke FW, Myers PR, Bates JN, Harrison DG: Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin. Am J Physiol 1990; 258: H515–20.","DOI":"10.1152\/ajpheart.1990.258.2.H515"},{"key":"10.3238\/arztebl.m2023.0205_ref26","doi-asserted-by":"crossref","unstructured":"Bairey Merz CN, Pepine CJ, Walsh MN, Fleg JL: Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation 2017; 135: 1075–92.","DOI":"10.1161\/CIRCULATIONAHA.116.024534"},{"key":"10.3238\/arztebl.m2023.0205_ref27","doi-asserted-by":"crossref","unstructured":"Mehta PK, Goykhman P, Thomson LE, et al.: Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc Imaging 2011; 4: 514–22.","DOI":"10.1016\/j.jcmg.2011.03.007"},{"key":"10.3238\/arztebl.m2023.0205_ref28","doi-asserted-by":"crossref","unstructured":"Villano A, Di Franco A, Nerla R, et al.: Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. Am J Cardiol 2013; 112: 8–13.","DOI":"10.1016\/j.amjcard.2013.02.045"},{"key":"10.3238\/arztebl.m2023.0205_ref29","doi-asserted-by":"crossref","unstructured":"Bairey Merz CN, Handberg EM, Shufelt CL, et al.: A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve. Eur Heart J 2016; 37: 1504–13.","DOI":"10.1093\/eurheartj\/ehv647"},{"key":"10.3238\/arztebl.m2023.0205_ref30","doi-asserted-by":"crossref","unstructured":"Rambarat CA, Elgendy IY, Handberg EM, et al.: Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women‘s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study. Int J Cardiol 2019; 276: 8–13.","DOI":"10.1016\/j.ijcard.2018.09.081"},{"key":"10.3238\/arztebl.m2023.0205_ref31","doi-asserted-by":"crossref","unstructured":"Skalidis EI, Hamilos MI, Chlouverakis G, Zacharis EA, Vardas PE: Ivabradine improves coronary flow reserve in patients with stable coronary artery disease. Atherosclerosis 2011; 215: 160–5.","DOI":"10.1016\/j.atherosclerosis.2010.11.035"},{"key":"10.3238\/arztebl.m2023.0205_ref32","doi-asserted-by":"crossref","unstructured":"Ong P, Athanasiadis A, Sechtem U: Pharmacotherapy for coronary microvascular dysfunction. Eur Heart J Cardiovasc Pharmacother 2015; 1: 65–71.","DOI":"10.1093\/ehjcvp\/pvu020"},{"key":"10.3238\/arztebl.m2023.0205_ref33","doi-asserted-by":"crossref","unstructured":"Lanza GA, Parrinello R, Figliozzi S: Management of microvascular angina pectoris. Am J Cardiovasc Drugs 2014; 14: 31–40.","DOI":"10.1007\/s40256-013-0052-1"},{"key":"10.3238\/arztebl.m2023.0205_ref34","doi-asserted-by":"crossref","unstructured":"Bairey Merz CN, Pepine CJ, Shimokawa H, Berry C: Treatment of coronary microvascular dysfunction. Cardiovasc Res 2020; 116: 856–70.","DOI":"10.1093\/cvr\/cvaa006"},{"key":"10.3238\/arztebl.m2023.0205_ref35","doi-asserted-by":"crossref","unstructured":"Ekre O, Eliasson T, Norrsell H, W\u00e4hrborg P, Mannheimer C: Electrical stimulation versus coronary artery bypass surgery in severe angina P: long-term effects of spinal cord stimulation and coronary artery bypass grafting on quality of life and survival in the ESBY study. Eur Heart J 2002; 23: 1938–45.","DOI":"10.1053\/euhj.2002.3286"},{"key":"10.3238\/arztebl.m2023.0205_ref36","doi-asserted-by":"crossref","unstructured":"Ferreira Reis J, Brizido C, Madeira S, Ramos R, Almeida M, Cacela D: Coronary sinus reducer device for the treatment of refractory angina: a multicenter initial experience. Rev Port Cardiol 2023; 42: 413–20.","DOI":"10.1016\/j.repc.2022.05.010"},{"key":"10.3238\/arztebl.m2023.0205_ref37","doi-asserted-by":"crossref","unstructured":"Cheng K, Keramida G, Baksi AJ, de Silva R: Implantation of the coronary sinus reducer for refractory angina due to coronary microvascular dysfunction in the context of apical hypertrophic cardiomyopathy-a case report. Eur Heart J Case Rep 2022; 6: ytac440.","DOI":"10.1093\/ehjcr\/ytac440"},{"key":"10.3238\/arztebl.m2023.0205_ref38","doi-asserted-by":"crossref","unstructured":"Giannini F, Baldetti L, Ielasi A, et al.: First experience with the coronary sinus reducer system for the management of refractory angina in patients without obstructive coronary artery disease. JACC Cardiovasc Interv 2017; 10: 1901–3.","DOI":"10.1016\/j.jcin.2017.06.062"},{"key":"10.3238\/arztebl.m2023.0205_ref39","doi-asserted-by":"crossref","unstructured":"Neglia D, Fommei E, Varela-Carver A, et al.: Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension. J Hypertens 2011; 29: 364–72.","DOI":"10.1097\/HJH.0b013e328340a08e"},{"key":"10.3238\/arztebl.m2023.0205_ref40","doi-asserted-by":"crossref","unstructured":"Zhang X, Li Q, Zhao J, et al.: Effects of combination of statin and calcium channel blocker in patients with cardiac syndrome X. Coron Artery Dis 2014; 25: 40–4.","DOI":"10.1097\/MCA.0000000000000054"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2023.0205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T11:38:08Z","timestamp":1698147488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2023.0205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":40,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2023.0205","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]}}}